SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

The $CAW cryptocurrency, also known as crow with knife, is trending as the community rallies behind its multi-chain functionality, bridging across $SOL, $BSC, $CRO, and $ETH (BASE) using Layerzero technology. Community members highlight its deflationary mechanisms and organic growth, while also mentioning potential staking opportunities. The focus remains on its unique branding and strong community engagement within the meme coin sector.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community discusses potential staking opportunities and meme coin integrations within its ecosystem. Conversations highlight Solana's strong setup and positive trend, with some anticipating a potential move towards new highs. Community members are also closely watching various meme coins built on Solana, such as $CAW and $UPDOG.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Crypto.com Coin ($CRO) is trending as the community debates its potential, with some expressing frustration over its price action compared to other cryptocurrencies like $BNB. Discussions include speculation about market manipulation and the impact of partnerships, as well as potential catalysts like a Cronos ETF and the broader adoption of crypto. Meanwhile, the memecoin $CAW, aka crow with knife, is seeing increased interest across multiple chains including $CRO.

Bonk refers to a series of comic-style memes in which meme characters such as Doge and Cheems get hit on the head with bats, hammers and other heavy objects, accompanied by the “Bonk” sound effect and clipart. The original image that spawned the meme depicts a Shiba Inu, named Copper. Bonk brings this humor on-chain, transforming the classic meme into a tokenized digital movement powered by community and culture.

Copper Inu

Copper Inu ($COPPER) is trending amid community discussions about its chart patterns and potential for a breakout, particularly in relation to other tokens like $SOL and $BTC. Some users are pointing to its name as indicative of strength, while others express concerns about potential scams.

Recall is a decentralized skill market for AI where communities fund, rank, and discover the AI solutions they need. Instead of corporations pushing one-size-fits-all AI, Recall flips the dynamic—communities signal demand, developers compete to deliver, and performance determines visibility.

Recall

RECALL CRYPTO is trending due to its recent ICO, with community members actively discussing its potential and current price action. High volume and new highs are fueling interest, though some caution against potential risks associated with new cryptocurrencies. The community is also comparing RECALL to other cryptocurrencies and exploring its potential within the broader crypto market.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is buzzing as traders discuss its AI strategy and potential for long-term gains, with community members pointing to open-source AI initiatives and data center investments as key catalysts. Some traders are eyeing upcoming earnings, anticipating a significant move, while others debate short-term bearish signals versus the stock's overall bullish outlook. The stock's valuation relative to its peers and potential impact from broader market factors, including geopolitical events and interest rate decisions, are also being closely monitored.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.

ATAI Life Sciences N.V.

ATAI Life Sciences is trending following news of FDA breakthrough therapy designation for their depression treatment, BPL-003, and a public offering. The community is actively discussing the potential for fast-tracked approval and its implications for the mental health sector. Some are drawing comparisons to GW Pharma and speculating on future market capitalization.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is trending as the community discusses analyst ratings updates and anticipation for upcoming earnings. Some reports focus on the company's strategic moves in Guyana and the Permian Basin, while others highlight its cost-cutting initiatives. Option traders are actively positioning, reacting to technical indicators and potential price movements.

Dominion Energy, Inc. engages in the production and distribution of energy. It operates through following business segments: Dominion Energy Virginia, Dominion Energy South Carolina, Contracted Energy, and Corporate and Other. The Corporate and Other segment focuses on corporate, service company, non-controlling interest in Dominion privatization, and non-regulated retail energy marketing operations. The company was founded by William W. Berry in 1983 and is headquartered in Richmond, VA.

Dominion Energy Inc

Dominion Energy is trending as investors weigh the impact of rising electricity demand from AI and data centers, alongside discussions about the company's dividend and strategic direction. The community is actively debating Dominion's potential within the evolving energy landscape, particularly in light of both bullish Elliott Wave analyses projecting significant upside and concerns around debt and renewable energy investments. Several analysts have adjusted their ratings and price targets, contributing to the ongoing conversation around the utility stock.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Delcath Systems (DCTH) is trending due to positive #esmo2025 CHOPIN trial data, with investors actively discussing the potential for a buyout or significant stock upside. Community members are focused on survival rates of combined therapies, with some expressing long-held confidence and others referencing past investment experiences with the stock. The discussions occur within the context of Delcath's work in interventional oncology.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharma stocks crack, Nifty Pharma Index slips over 2% as Trump unveils 100% tariff: 3 key factors investors must watch

… and patented drugs entering … pharma space include the likes of Natco Pharma , Laurus Labs, Alembic Pharma , Sun Pharma … , Gland Pharma , Ajanta Pharma , and Glenmark Pharmaceuticals … of Indian pharmaceutical exports. …

India's $30B Pharma Export Market Faces Heat from Trump's Tariff

… on branded and patented pharmaceuticals , as announced by President … on branded and patented pharmaceutical products beginning October 1, … Aurobindo Pharma , Zydus Lifesciences, Sun Pharma and Gland Pharma derive between … to make high-end drugs such as cancer and …

Healthcare stocks in India fell on Friday as investors weighed the impact of U.S. President Donald Trump’s move to impose a 100% tariff on branded and patented drugs starting Oct. 1.&nbsp;The measure, announced in late-night Truth Social posts, exempts only those manufacturers with U.S. plants that are already under construction or have broken ground.The Nifty Healthcare index fell 1.2% on Thursday, with 18 of its 20 components trading lower.&nbsp;IPCA Laboratories remained unchanged, while Torrent Pharma rose 0.01%.Analyst ViewSEBI-registered analyst&nbsp;<a href="https://stocktwits.com/ra_vishaltrehan">Vishal Trehan</a> said Gland Pharma is the most exposed, given its lack of a U.S. manufacturing footprint and reliance on branded or patented formulations.&nbsp;<stembedurl>https://stocktwits.com/ra_vishaltrehan/message/630078378</stembedurl>He noted that Syngene International, Piramal Pharma, and Zydus Lifesciences stand to benefit from their contract manufacturing models and biologics portfolios, which are less tariff-sensitive.Trehan also pointed out that companies with a large branded generics or biosimilars presence, such as Dr. Reddy’s Laboratories and Biocon, will need to accelerate U.S. production to avoid margin erosion.Trump’s Pharma TariffsThe announcement builds on Trump’s escalating trade measures aimed at repatriating drug manufacturing. Last month, he outlined a phased plan, beginning with a “small tariff” on imported drugs, before lifting duties to 150% within 18 months and ultimately to 250%.&nbsp;Pharmaceuticals had earlier been excluded from his reciprocal tariff program, but the new rules extend to prescription medicines, biologics, specialty drugs, and over-the-counter products, with generic drugs remaining exempt.What Is The Retail Mood?On Stocktwits, retail sentiment for Piramal Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories was ‘bearish’ amid ‘normal’ message volume.So far this year,&nbsp;<a href="https://stocktwits.com/symbol/GLAND.NSE">Gland Pharma</a> has risen 6.5%, while&nbsp;<a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene International</a> is down 29.1%,&nbsp;<a href="https://stocktwits.com/symbol/PPLPHARMA.NSE">Piramal Pharma</a> has slipped 25.9%,&nbsp;<a href="https://stocktwits.com/symbol/ZYDUSLIFE.NSE">Zydus Lifesciences</a> is up 1.8%,&nbsp;<a href="https://stocktwits.com/symbol/DRREDDY.NSE">Dr. Reddy’s Laboratories</a> is down 7.2%, and&nbsp;<a href="https://stocktwits.com/symbol/BIOCON.NSE">Biocon</a> has fallen 6.3%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

India’s Healthcare Index Sinks After Trump’s Pharma Tariff Blow — SEBI Analyst Sees Risks For Gland, Biocon, Dr. Reddy’s

The analyst noted that Syngene, Piramal Pharma, and Zydus Lifesciences may be better positioned, as their contract manufacturing models and biologics portfolios are less susceptible to the tariff impact.

Equity

Business News | Trump's 100% Tariff on Patented Drugs Puts Spotlight on India's USD 30 Billion Pharma Export Market

… on branded and patented pharmaceutical products beginning October 1 … Aurobindo Pharma , Zydus Lifesciences, Sun Pharma and Gland Pharma derive … to make high-end drugs such as cancer … Company IS BUILDING their Pharmaceutical Manufacturing Plant in America. …

US President Donald Trump Announces Tariffs Up To 100% On Pharma, Starting October 1, 2025

India supplies over 45 per cent of generic and 15 per cent of biosimilar drugs used in the US. Firms like Dr Reddy's, Aurobindo Pharma, Zydus Lifesciences, Sun Pharma, and Gland Pharma reportedly earn anywhere from 30-50 per cent of their total revenues from the American market.

Why has US goverment given exemption to Indian pharmaceutical sector

The US granted a crucial exemption to India’s pharmaceutical industry from recent tariffs, recognizing the critical role of Indian generics in maintaining affordable healthcare. While initially a 50% tariff was imposed, the exemption protects the sector, preventing disruption to US drug access. Major Indian pharmaceutical players like Zydus Lifesciences, Dr. Reddy’s, Gland Pharma, and Biocon, heavily reliant on the US market, would be significantly impacted.

Gland Pharma Ltd. manufactures pharmaceutical ingredients and injectable formulations. It offers injectables including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, and ophthalmic solutions. The company was founded by P. V. N. Raju in 1978 and is headquartered in Sangareddy, India.

Current Price	1,933.10
Prev Close	1,918.80
Open	1,923.60
Dividend Yield	1.13%
50-Day Moving Average	1,948.01
Beta	-0.05
Avg. Volume	228,138.05
PE Ratio	41.45

52-Week High	2,131.00
52-Week Low	1,277.80
Market Capitalization	319.26B
EPS (Annual)	42.40
Price to Book	3.49
Revenue Per Employee	12.85M
Enterprise Value/EBITDA	N/A

GLAND.NSE
Gland Pharma Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLAND.NSE News

GLAND.NSEGland Pharma Ltd.